TREPPO, Elena
 Distribuzione geografica
Continente #
NA - Nord America 179
EU - Europa 70
AS - Asia 24
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 280
Nazione #
US - Stati Uniti d'America 176
IT - Italia 29
IE - Irlanda 13
VN - Vietnam 12
CN - Cina 5
NL - Olanda 4
SG - Singapore 4
TG - Togo 4
CA - Canada 3
PL - Polonia 3
BE - Belgio 2
CH - Svizzera 2
DE - Germania 2
FI - Finlandia 2
FR - Francia 2
GB - Regno Unito 2
HK - Hong Kong 2
RU - Federazione Russa 2
SE - Svezia 2
UA - Ucraina 2
AR - Argentina 1
AU - Australia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GR - Grecia 1
IN - India 1
RO - Romania 1
Totale 280
Città #
Chandler 29
Dublin 13
Dong Ket 12
Ann Arbor 11
Wilmington 9
Woodbridge 9
Ashburn 8
Princeton 8
Fairfield 7
Udine 7
Cambridge 6
Milan 6
Ogden 6
Seattle 5
Amsterdam 4
Beijing 4
Houston 4
Lomé 4
Buffalo 3
Singapore 3
Toronto 3
Warsaw 3
Brussels 2
Codroipo 2
Florence 2
Hong Kong 2
Jacksonville 2
Lappeenranta 2
Lucca 2
North Charleston 2
Redmond 2
St Petersburg 2
Trieste 2
el Pertus 2
Addis Ababa 1
Andover 1
Athens 1
Boardman 1
Brno 1
Bucharest 1
Des Moines 1
Gorizia 1
Grafing 1
Hyderabad 1
Melbourne 1
Munich 1
Norwalk 1
Quilmes 1
Rome 1
San Diego 1
Treppo Grande 1
Venezia 1
Zhengzhou 1
Totale 207
Nome #
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) 59
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 34
Rituximab induction and maintenance in ANCA-associated vasculitis: State of the art and future perspectives 31
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 29
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases 22
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 22
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis 19
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 18
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 14
Rheumatologic manifestations of Hepatitis C Virus 13
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 10
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 9
Paraproteinemias Associated with Autoimmune Diseases 8
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak 8
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis 8
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 7
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 7
The paradigm shift in ANCA-Associated vasculitis: Prime time for the complement targeting 6
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 5
Systemic vasculitis: one year in review 2024 5
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years 4
Totale 338
Categoria #
all - tutte 3.169
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 5 4 4 4 4 0
2020/202159 1 4 6 4 0 4 3 8 8 4 4 13
2021/202258 4 2 6 4 0 0 9 6 0 10 7 10
2022/202394 10 4 11 5 10 15 0 5 15 11 4 4
2023/202498 15 10 9 3 13 3 1 4 9 11 8 12
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 338